Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization (Q30419179)

21 June 2017

Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization (English)

1 reference

21 June 2017

0 references

1 reference

1 reference

1 reference

Vicente Martín

5

0 references

Pere Godoy

Pere Godoy

3

0 references

José M. Quintana

José María Quintana

8

0 references

Jordi Alonso

16

Jordi Alonso

1 reference

ORCID Public Data File 2021

21 June 2017

1 reference

Fernando González-Candelas

11

Fernando González-Candelas

1 reference

21 June 2017

10

Jenaro Astray

1 reference

Ady Angelica Castro-acosta

21 June 2017

14

Ady Castro

1 reference

21 June 2017

15

Maretva Baricot

1 reference

21 June 2017

1

Angela Domínguez

1 reference

21 June 2017

Jesús Castilla

2

1 reference

21 June 2017

Miguel Delgado-Rodríguez

4

1 reference

21 June 2017

Marc Saez

6

1 reference

21 June 2017

Núria Soldevila

7

1 reference

21 June 2017

José María Mayoral

9

1 reference

21 June 2017

Rafael Cantón

12

1 reference

21 June 2017

Sonia Tamames

13

1 reference

21 June 2017

Tomás Pumarola

17

1 reference

21 June 2017

CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain

18

1 reference

21 June 2017

language of work or name

English

0 references

publication date

10 July 2012

1 reference

21 June 2017

1 reference

21 June 2017

30

1 reference

21 June 2017

5644-5650

1 reference

21 June 2017

38

1 reference

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

The central role of the propensity score in observational studies for causal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.090

10.1016/J.VACCINE.2012.06.090

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference